logo

Acer Therapeutics Inc. (ACER)



Trade ACER now with
  Date
  Headline
12/22/2020 8:49:36 AM Acer Reports Full Enrollment Of Pivotal Bioequivalence Trial Of ACER-001 For Urea Cycle Disorders
6/25/2019 8:37:52 AM Acer Therapeutics Receives Complete Response Letter From FDA For Use Of EDSIVO In VEDS Patients
1/2/2019 8:35:20 AM Acer Therapeutics Enters Exclusive License Agreement With Sanofi To Acquire Worldwide Rights To Osanetant
12/26/2018 8:32:19 AM Acer Therapeutics Reports FDA Acceptance Of NDA And Priority Review For EDSIVO For The Treatment Of VEDS
11/12/2018 7:04:19 AM William Blair Is Increasing Acer Therapeutics Inc. (ACER) FY19 Estimate To -1.06 From -1.41
11/12/2018 7:04:00 AM William Blair Is Raising Acer Therapeutics Inc. (ACER) FY18 Estimate To -2.04 From -2.29
10/29/2018 8:33:23 AM Acer Therapeutics Submits NDA For EDSIVO For Treatment Of VEDS
8/16/2018 4:02:24 PM HTG Molecular Appoints Michelle Griffin To Its Board Of Directors
8/14/2018 7:08:54 AM William Blair Is Cutting Acer Therapeutics Inc. (ACER) FY19 Estimate To -1.41 From -1.13
8/14/2018 7:08:38 AM William Blair Is Lowering Acer Therapeutics Inc. (ACER) FY18 Estimate To -2.29 From -2.22
8/14/2018 7:07:42 AM William Blair Reiterates Acer Therapeutics Inc. (ACER) At Outperform
8/13/2018 4:11:37 PM Acer Therapeutics Q2 Loss/share $0.64 Vs. Loss $1.29 Year Ago
8/3/2018 4:07:33 PM Acer Therapeutics Announces Closing Of Underwritten Public Offering